189 related articles for article (PubMed ID: 36920696)
1. Pseudotyped Viruses for Influenza.
Del Rosario JMM; da Costa KAS; Temperton NJ
Adv Exp Med Biol; 2023; 1407():153-173. PubMed ID: 36920696
[TBL] [Abstract][Full Text] [Related]
2. Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design.
da Costa KAS; Del Rosario JMM; Ferrari M; Vishwanath S; Asbach B; Kinsley R; Wagner R; Heeney JL; Carnell GW; Temperton NJ
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146598
[TBL] [Abstract][Full Text] [Related]
3. Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies.
Ferrara F; Del Rosario JMM; da Costa KAS; Kinsley R; Scott S; Fereidouni S; Thompson C; Kellam P; Gilbert S; Carnell G; Temperton N
Front Immunol; 2021; 12():661379. PubMed ID: 34108964
[TBL] [Abstract][Full Text] [Related]
4. Use of lentiviral pseudotypes as an alternative to reassortant or Triton X-100-treated wild-type Influenza viruses in the neuraminidase inhibition enzyme-linked lectin assay.
Biuso F; Palladino L; Manenti A; Stanzani V; Lapini G; Gao J; Couzens L; Eichelberger MC; Montomoli E
Influenza Other Respir Viruses; 2019 Sep; 13(5):504-516. PubMed ID: 31411006
[TBL] [Abstract][Full Text] [Related]
5. Antigenic commonality and divergence of hemagglutinin-esterase-fusion protein among influenza D virus lineages revealed using epitope mapping.
Katayama M; Murakami S; Ishida H; Matsugo H; Sekine W; Ohira K; Takenaka-Uema A; Horimoto T
J Virol; 2024 Mar; 98(3):e0190823. PubMed ID: 38345383
[TBL] [Abstract][Full Text] [Related]
6. Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase.
Tsai C; Caillet C; Hu H; Zhou F; Ding H; Zhang G; Zhou B; Wang S; Lu S; Buchy P; Deubel V; Vogel FR; Zhou P
Vaccine; 2009 Nov; 27(48):6777-90. PubMed ID: 19732860
[TBL] [Abstract][Full Text] [Related]
7. Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.
Prachanronarong KL; Canale AS; Liu P; Somasundaran M; Hou S; Poh YP; Han T; Zhu Q; Renzette N; Zeldovich KB; Kowalik TF; Kurt-Yilmaz N; Jensen JD; Bolon DNA; Marasco WA; Finberg RW; Schiffer CA; Wang JP
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381484
[TBL] [Abstract][Full Text] [Related]
8. Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection.
Del Rosario JMM; da Costa KAS; Asbach B; Ferrara F; Ferrari M; Wells DA; Mann GS; Ameh VO; Sabeta CT; Banyard AC; Kinsley R; Scott SD; Wagner R; Heeney JL; Carnell GW; Temperton NJ
Vaccines (Basel); 2021 Jul; 9(7):. PubMed ID: 34358157
[TBL] [Abstract][Full Text] [Related]
9. Characterization of lentiviral pseudotypes with influenza H5N1 hemagglutinin and their performance in neutralization assays.
Wang W; Xie H; Ye Z; Vassell R; Weiss CD
J Virol Methods; 2010 May; 165(2):305-10. PubMed ID: 20153374
[TBL] [Abstract][Full Text] [Related]
10. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
[TBL] [Abstract][Full Text] [Related]
11. Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study.
Bernard MC; Waldock J; Commandeur S; Strauß L; Trombetta CM; Marchi S; Zhou F; van de Witte S; van Amsterdam P; Ho S; Hoschler K; Lugovtsev V; Weir JP; Montomoli E; Cox RJ; Engelhardt OG; Friel D; Wagner R; Ollinger T; Germain S; Sediri-Schön H
Front Immunol; 2022; 13():909297. PubMed ID: 35784305
[TBL] [Abstract][Full Text] [Related]
12. Evolution and Antigenic Advancement of N2 Neuraminidase of Swine Influenza A Viruses Circulating in the United States following Two Separate Introductions from Human Seasonal Viruses.
Kaplan BS; Anderson TK; Chang J; Santos J; Perez D; Lewis N; Vincent AL
J Virol; 2021 Sep; 95(20):e0063221. PubMed ID: 34379513
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analyses of all influenza type A viral hemagglutinins and neuraminidases using universal antibodies in simple slot blot assays.
Gravel C; Li C; Wang J; Hashem AM; Jaentschke B; Van Domselaar G; He R; Li X
J Vis Exp; 2011 Apr; (50):. PubMed ID: 21490585
[TBL] [Abstract][Full Text] [Related]
14. H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans.
Khurana S; Wu J; Verma N; Verma S; Raghunandan R; Manischewitz J; King LR; Kpamegan E; Pincus S; Smith G; Glenn G; Golding H
J Virol; 2011 Nov; 85(21):10945-54. PubMed ID: 21865396
[TBL] [Abstract][Full Text] [Related]
15. The Hemagglutinin-Esterase Fusion Glycoprotein Is a Primary Determinant of the Exceptional Thermal and Acid Stability of Influenza D Virus.
Yu J; Hika B; Liu R; Sheng Z; Hause BM; Li F; Wang D
mSphere; 2017; 2(4):. PubMed ID: 28808690
[TBL] [Abstract][Full Text] [Related]
16. A vesicular stomatitis pseudovirus expressing the surface glycoproteins of influenza A virus.
Cheresiz SV; Kononova AA; Razumova YV; Dubich TS; Chepurnov AA; Kushch AA; Davey R; Pokrovsky AG
Arch Virol; 2014 Oct; 159(10):2651-8. PubMed ID: 24888312
[TBL] [Abstract][Full Text] [Related]
17. A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages.
Carlock MA; Ross TM
Sci Rep; 2023 Sep; 13(1):15911. PubMed ID: 37741893
[TBL] [Abstract][Full Text] [Related]
18. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
[TBL] [Abstract][Full Text] [Related]
19. Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity.
Eichelberger MC; Couzens L; Gao Y; Levine M; Katz J; Wagner R; Thompson CI; Höschler K; Laurie K; Bai T; Engelhardt OG; ; Wood J
Vaccine; 2016 Jan; 34(4):458-465. PubMed ID: 26707221
[TBL] [Abstract][Full Text] [Related]
20. VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
Kuck LR; Byrne-Nash R; Gillis J; Bueter K; Couzens LK; Eichelberger MC; Rowlen KL
Vaccine; 2018 May; 36(21):2937-2945. PubMed ID: 29699789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
